Simplicity Wealth’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$394K Buy
2,149
+197
+10% +$36.3K 0.02% 519
2025
Q4
$344K Buy
1,952
+176
+10% +$28.8K 0.02% 519
2025
Q3
$249K Sell
1,776
-1,648
-48% -$223K 0.01% 612
2025
Q2
$430K Buy
+3,424
New +$427K 0.02% 491
2024
Q3
Sell
-1,831
Closed -$424K 556
2024
Q2
$424K Sell
1,831
-232
-11% -$50.4K 0.01% 820
2024
Q1
$445K Buy
+2,063
New +$483K 0.01% 779

Other funds holding BIIB

Simplicity Wealth's BIIB Position: Q1 2026 in Review

Simplicity Wealth increased its Biogen (BIIB) stake by 10% in Q1 2026, buying an estimated $36.3K and bringing the position to 2,149 shares worth $394K. The position accounts for 0.02% of the portfolio, ranked #519.

Simplicity Wealth first reported a position in BIIB in Q1 2024 and has held it in 6 quarters since. The position peaked at $445K in Q1 2024. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Simplicity Wealth held 2,149 shares of Biogen worth $394K as of Q1 2026.
  • Simplicity Wealth bought 197 Biogen shares in Q1 2026, an estimated $36.3K.
  • Biogen made up 0.02% of Simplicity Wealth's portfolio in Q1 2026, its #519 holding.
  • Simplicity Wealth first reported a position in Biogen in Q1 2024 and has held it in 6 quarters since.
  • Simplicity Wealth's Biogen position peaked at $445K in Q1 2024.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Simplicity Wealth's 13F filing for Q1 2026, filed 30 Apr 2026.